{"version":1,"type":"story","url":"https://digestai.news/story/study-finds-gpt-5-6-sol-offers-competitive-cancer-survival-estimates","json":"https://digestai.news/story/study-finds-gpt-5-6-sol-offers-competitive-cancer-survival-estimates.json","markdown":"https://digestai.news/story/study-finds-gpt-5-6-sol-offers-competitive-cancer-survival-estimates.md","slug":"study-finds-gpt-5-6-sol-offers-competitive-cancer-survival-estimates","headline":"Study finds GPT-5.6-Sol offers competitive cancer survival estimates","summary":"Researchers introduced Survprompt, a framework that converts structured patient data into text prompts to test whether large language models can predict cancer survival without specialized training. The study evaluated frontier LLMs against conventional models, including random survival forests, using two multi-institutional pan-cancer cohorts: the public MSK-CHORD dataset and a new cohort from Providence St. Joseph Health Network.\n\nThe results showed that GPT-5.6-Sol achieved censored mean absolute error (cMAE) within 10% of state-of-the-art specialized models for several cancer types. Notably, the LLM outperformed the specialized models for prostate cancer in the MSK-CHORD cohort. Feature ablations indicated that LLMs prioritized similar clinical variables as traditional survival models.\n\nHowever, the study highlights significant limitations. LLMs displayed inconsistent accuracy across different cancer types and institutions. They also performed poorly in discriminating between high-risk and low-risk patients, resulting in lower concordance index scores. While zero-shot LLMs can generate surprisingly accurate prognostic estimates, their variable performance remains a barrier to clinical use.","keyPoints":["Survprompt framework tests LLMs on survival prediction using MSK-CHORD and Providence St. Joseph Health data.","GPT-5.6-Sol achieved cMAE within 10% of specialized models for several cancer types.","LLMs showed inconsistent accuracy across institutions and poor discrimination between risk levels."],"whyItMatters":"This research suggests LLMs may serve as accessible tools for preliminary medical risk assessment, though their inconsistency and poor risk discrimination currently limit direct clinical application.","category":{"slug":"research","name":"Research","url":"https://digestai.news/category/research"},"entities":{"companies":["Providence St. Joseph Health Network"],"models":["GPT-5.6-Sol"],"people":[]},"firstPublishedAt":"2026-10-01T04:00:00Z","updatedAt":"2026-10-01T04:00:00Z","sourceCount":1,"hasPrimarySource":true,"sources":[{"outlet":"arXiv cs.CL","title":"Large Language Models are Approximate Survival Estimators","url":"https://arxiv.org/abs/2609.38181","publishedAt":"2026-10-01T04:00:00Z","type":"primary","primary":true,"lead":true}],"sourceNotes":null,"discussions":[],"thread":null,"cite":{"text":"Digest AI, \"Study finds GPT-5.6-Sol offers competitive cancer survival estimates\", 1 October 2026, https://digestai.news/story/study-finds-gpt-5-6-sol-offers-competitive-cancer-survival-estimates","publisher":"Digest AI","title":"Study finds GPT-5.6-Sol offers competitive cancer survival estimates","datePublished":"2026-10-01T04:00:00Z","url":"https://digestai.news/story/study-finds-gpt-5-6-sol-offers-competitive-cancer-survival-estimates"},"generatedBy":"Written by Digest AI's editorial model from the linked sources; the sources are the record.","license":"Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse"}